Enlila Health Acquires U.S. Biotech Leader Crescenta

Work Capital’s biotechnology strategy is amplified as Enlila Health acquires Crescenta Biosciences in the United States.

Biotech Revolution: Enlila’s Acquisition of Crescenta

Enlila Health, a subsidiary of Türkiye İş Bankası Group, has taken majority control of Crescenta Biosciences through a capital increase backed by a 10% stake from Harvard University, boosting its international competitiveness in biotechnology.

Strategic Financial Leap: Harvard Partnership and Capital Increase

■Enlila, with its 10% stake from Harvard University, has acquired Crescenta’s majority shares.

■The deal accelerates Work Capital’s growth strategy in biotechnology on a global scale.

■The shared vision of Kubilay Aykol and Emre Koyuncu will expedite clinical research worldwide.

Operational Synergy: Scientific Foundations and Clinical Objectives

Enlila’s Harvard University academic infrastructure merges with Crescenta’s focus on fatty‑acid‑binding proteins and immunometabolism, accelerating the transition of deep‑tech projects into clinical phases.

Market Reaction: Investor and Competitive Attention

■The investment will serve as leverage for developing innovative therapies in the U.S. biotech market.

■Work Capital’s portfolio, combined with Enlila and Crescenta, positions Turkey as a benchmark in the global biotech ecosystem.

■The competitive landscape shows a high growth potential compared to similar U.S. investments.

Future Outlook: Implications for Turkey’s Biotech Ecosystem

■Strategic partnerships are critical for Turkey to become globally competitive in biotechnology.

■Enlila’s partnership with Harvard provides an opportunity to showcase Turkish scholars on the international stage.

■The investment will support the entrepreneurial ecosystem’s growth and indirectly address structural unemployment issues.

The importance of strategic investments to enhance Turkey’s global competitiveness in biotechnology goes beyond capital flow; it is measured by fostering academic collaboration and strengthening the innovation ecosystem. The union of Enlila and Crescenta exemplifies this effort, setting a model for sustainable growth locally and globally.